Citigroup Raises Becton, Dickinson and Company (NYSE:BDX) Price Target to $282.00
Becton, Dickinson and Company (NYSE:BDX – Free Report) had its target price boosted by Citigroup from $260.00 to $282.00 in a report released on Monday, Marketbeat.com reports. Citigroup currently has a neutral rating on the medical instruments supplier’s stock. BDX has been the topic of several other reports. Piper Sandler lifted their price target on […]